These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 22823891)

  • 1. Biocompatibility of mesoporous silica nanoparticles.
    Asefa T; Tao Z
    Chem Res Toxicol; 2012 Nov; 25(11):2265-84. PubMed ID: 22823891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
    Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
    ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
    Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
    ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shape-mediated biological effects of mesoporous silica nanoparticles.
    Hao N; Li L; Tang F
    J Biomed Nanotechnol; 2014 Oct; 10(10):2508-38. PubMed ID: 25992407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
    Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
    ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
    Hu JJ; Xiao D; Zhang XZ
    Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
    Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
    Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica nanoparticles in tissue engineering--a perspective.
    Rosenholm JM; Zhang J; Linden M; Sahlgren C
    Nanomedicine (Lond); 2016 Feb; 11(4):391-402. PubMed ID: 26784861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
    Chen Z; Li X; He H; Ren Z; Liu Y; Wang J; Li Z; Shen G; Han G
    Colloids Surf B Biointerfaces; 2012 Jun; 95():274-8. PubMed ID: 22494670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores.
    Na HK; Kim MH; Park K; Ryoo SR; Lee KE; Jeon H; Ryoo R; Hyeon C; Min DH
    Small; 2012 Jun; 8(11):1752-61. PubMed ID: 22454257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of mesoporous silica nanoparticles.
    Wu SH; Mou CY; Lin HP
    Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.
    He Q; Zhang J; Shi J; Zhu Z; Zhang L; Bu W; Guo L; Chen Y
    Biomaterials; 2010 Feb; 31(6):1085-92. PubMed ID: 19880176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.